Clear cell carcinomas of the ovary have poorer outcomes compared with serous carcinomas: Results from a single-center Taiwanese study
Open Access
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 117 (2) , 117-125
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology (102-2628-B-182-016-MY3)
- Ministry of Health and Welfare (DOHW105-TDU-B-212-113003)
This publication has 30 references indexed in Scilit:
- Serum microRNAs in clear cell carcinoma of the ovaryTaiwanese Journal of Obstetrics and Gynecology, 2014
- Ovarian cancerThe Lancet, 2014
- Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancyThe Journal of Pathology, 2014
- Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in TaiwanJournal of Gynecologic Oncology, 2013
- Clear cell carcinoma of the ovary: A review of the literatureGynecologic Oncology, 2012
- Rethinking ovarian cancer: recommendations for improving outcomesNature Reviews Cancer, 2011
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell CarcinomaScience, 2010
- Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell CarcinomaThe American Journal of Pathology, 2009
- Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancersGynecologic Oncology, 2008
- Clinical characteristics of clear cell carcinoma of the ovaryCancer, 2000